We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EMA at Odds With Parliament Over Retention of Master Files
EMA at Odds With Parliament Over Retention of Master Files
February 27, 2013
Master files of trials used for marketing authorization applications should be retained for at least 15 years following completion or discontinuation of the study, or for two years after authorization is granted, the European Medicines Agency says.